Credit Suisse
-
The Swiss bank has put two emerging market bankers at risk; cuts also begin in DCM -
The Swiss bank's MD plans to work as an independent adviser
-
Deal covered 0.52 times as bookbuilding moves to final leg
-
Glocos relieved by 'better than anticipated' result
-
The chairman of SNB rules out increasing its stake in Credit Suisse but says an alliance between the two banks could be possible
-
Swiss lender hit with a flurry of downgrades as agencies respond to restructuring plan but the sale of its Securitized Products Group was seen as a positive for its credit
-
Bankers on the deal are confident about auctioning the remaining rights
-
Chemical company hits three points of the curve to fund upcoming acquisition
-
The Swiss lender has confirmed it will unwind operations in major emerging market countries but fate of individuals unclear
-
An international syndicate of 20 banks has been appointed to lead Credit Suisse's rights issue
-
- Who’s in - Who’s out - Who’s paying for it
-
Credit Suisse’s plan to fulfil the dreams of First Boston loyalists and create a semi-independent capital markets and advisory firm based in the US makes European investment banking a lower priority, writes David Rothnie
